Search Results - "Kamholz, John"
-
1
Post-COVID-19 Fatigue: Potential Contributing Factors
Published in Brain sciences (19-12-2020)“…Much of the spotlight for coronavirus disease 2019 (COVID-19) is on the acute symptoms and recovery. However, many recovered patients face persistent physical,…”
Get full text
Journal Article -
2
Response Variability in Transcranial Direct Current Stimulation: Why Sex Matters
Published in Frontiers in psychiatry (19-06-2020)Get full text
Journal Article -
3
Transcranial Direct Current Stimulation (tDCS) to Improve Gait in Multiple Sclerosis: A Timing Window Comparison
Published in Frontiers in human neuroscience (28-11-2019)“…Unilateral weakness of the lower limb is a hallmark of multiple sclerosis (MS) and a significant contributor to the progressive worsening of walking ability…”
Get full text
Journal Article -
4
Statin use and delayed onset of Huntington's disease
Published in Movement disorders (01-02-2019)“…ABSTRACT Background There is evidence to suggest that 3‐hydroxy‐3‐methyl‐glutaryl‐coenzyme A reductase inhibitors (statins) may be beneficial in Huntington's…”
Get full text
Journal Article -
5
tDCS improves perceptions of fatigue in patients with Post-COVID-19-symptoms that are less than 6 months post-infection
Published in Brain stimulation (01-01-2023)Get full text
Journal Article -
6
Evaluating depression and suicidality in tetrabenazine users with Huntington disease
Published in Neurology (17-07-2018)“…OBJECTIVETo determine whether tetrabenazine (TBZ) use is associated with an increased incidence of depression and/or suicidal ideation. METHODSIn this…”
Get full text
Journal Article -
7
Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness
Published in PloS one (26-04-2022)“…Trillions of microbes such as bacteria, fungi, and viruses exist in the healthy human gut microbiome. Although gut bacterial dysbiosis has been extensively…”
Get full text
Journal Article -
8
Autonomic dysregulation as an early pathologic feature of Huntington Disease
Published in Autonomic neuroscience (01-03-2021)“…Autonomic nervous system (ANS) dysfunction has been described in adults with motor-manifest Huntington's Disease (HD) or those who are near their predicted…”
Get full text
Journal Article -
9
Author response: Evaluating depression and suicidality in tetrabenazine users with Huntington disease
Published in Neurology (26-02-2019)Get full text
Journal Article -
10
Inhibitory modulation of cytochrome c oxidase activity with specific near-infrared light wavelengths attenuates brain ischemia/reperfusion injury
Published in Scientific reports (22-02-2018)“…The interaction of light with biological tissue has been successfully utilized for multiple therapeutic purposes. Previous studies have suggested that near…”
Get full text
Journal Article -
11
The Tolerability and Efficacy of 4 mA Transcranial Direct Current Stimulation on Leg Muscle Fatigability
Published in Brain sciences (23-12-2019)“…Transcranial direct current stimulation (tDCS) modulates cortical excitability and affects a variety of outcomes. tDCS at intensities ≤2 mA is well-tolerated,…”
Get full text
Journal Article -
12
Author response to Dr. Aziz—“Statin use and delayed onset of Huntington disease”
Published in Movement disorders (01-05-2019)Get full text
Journal Article -
13
Substance abuse may hasten motor onset of Huntington disease: Evaluating the Enroll-HD database
Published in Neurology (28-02-2017)“…OBJECTIVE:To investigate the relationship between substances of abuse and age at motor onset (AMO) in patients with Huntington disease (HD) in a large and…”
Get full text
Journal Article -
14
Transcranial Direct Current Stimulation and Post-COVID-19-Fatigue
Published in Brain stimulation (01-11-2021)Get full text
Journal Article -
15
Altered expression of SIRPγ on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells
Published in PloS one (27-08-2020)“…Factors regulating self-antigen directed immune-responses in autoimmunity are poorly understood. Signal regulatory protein gamma (SIRPγ) is a human T-cell…”
Get full text
Journal Article -
16
Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice
Published in Brain (London, England : 1878) (01-12-2012)“…Charcot–Marie–Tooth disease type 1B is caused by mutations in myelin protein zero. R98C mice, an authentic model of early onset Charcot–Marie–Tooth disease…”
Get full text
Journal Article -
17
The natural history of Pelizaeus–Merzbacher disease caused by PLP1 duplication: A multiyear case series
Published in Clinical case reports (01-09-2023)“…Key Clinical Message This study aimed to characterize the clinical features, developmental milestones, and the natural history of Pelizaeus–Merzbacher disease…”
Get full text
Journal Article -
18
Spinal Cord Infarction Presenting as a Hemicord Syndrome: Report of 2 Cases
Published in Journal of stroke and cerebrovascular diseases (01-06-2018)“…Infarction of the spinal cord is a rare entity in clinical practice. Limited literature exists on spinal cord stroke treatment, and the management is often…”
Get full text
Journal Article -
19
Comparing Risperidone and Olanzapine to Tetrabenazine for the Management of Chorea in Huntington Disease: An Analysis from the Enroll‐HD Database
Published in Movement disorders clinical practice (Hoboken, N.J.) (01-02-2019)“…ABSTRACT Introduction Huntington's chorea (HC) is commonly managed with neuroleptic medications, though there is little evidence to support their use. This…”
Get full text
Journal Article -
20
Neuroradiologic correlates of clinical disability and progression in the X-Linked leukodystrophy Pelizaeus–Merzbacher disease
Published in Journal of the neurological sciences (15-12-2013)“…Abstract Objective To determine whether quantitative measure of magnetic resonance imaging data from patients with the inherited leukodystrophy,…”
Get full text
Journal Article